Table 3.
|
|
|
Intervention group |
||||
---|---|---|---|---|---|---|---|
Characteristics | Control group ( n = 7) | p value | Intake frequency of <50% ile ( n = 12) | p value | Intake frequency of ≥50% ile ( n = 16) | p value | |
|
Baseline |
185 ± 32 |
|
222 ± 26 |
|
211 ± 27 |
|
T-Chol (mg/dL) |
|
|
0.191* |
|
0.229* |
|
0.006* |
|
After 3 months |
199 ± 40 |
|
215 ± 28 |
|
199 ± 22 |
|
|
Baseline |
105 ± 44 |
|
136 ± 30 |
|
127 ± 31 |
|
LDL-Chol (mg/dL) |
|
|
0.292* |
|
0.437* |
|
0.010* |
|
After 3 months |
109 ± 45 |
|
132 ± 26 |
|
116 ± 25 |
|
|
Baseline |
49 ± 17 |
|
53 ± 7 |
|
59 ± 11 |
|
HDL-Chol (mg/dL) |
|
|
0.522* |
|
0.287* |
|
0.073* |
|
After 3 months |
49 ± 16 |
|
51 ± 8 |
|
56 ± 15 |
|
|
Baseline |
240 ± 374 |
|
208 ± 116 |
|
121 ± 55 |
|
Triacylglycerol (mg/dL) |
|
|
0.173† |
|
0.136† |
|
0.408† |
|
After 3 months |
289 ± 436 |
|
181 ± 67 |
|
115 ± 51 |
|
|
Baseline |
113 ± 18 |
|
108 ± 19 |
|
118 ± 28 |
|
Glucose (mg/dL) |
|
|
0.735† |
|
0.583† |
|
0.255† |
|
After 3 months |
112 ± 21 |
|
107 ± 16 |
|
111 ± 18 |
|
|
Baseline |
5.0 ± 0.3 |
|
5.3 ± 0.5 |
|
5.5 ± 0.8 |
|
Hemoglobin A1C (%) |
|
|
0.041† |
|
0.033† |
|
0.529† |
|
After 3 months |
5.1 ± 0.2 |
|
5.4 ± 0.5 |
|
5.5 ± 0.7 |
|
|
Baseline |
3.5 ± 5.7 |
|
1.4 ± 2.0 |
|
1.9 ± 5.9 |
|
Active ghrelin (fmol/mL) |
|
|
0.128† |
|
0.008† |
|
.001† |
|
After 3 months |
6.4 ± 7.4 |
|
3.8 ± 3.9 |
|
5.3 ± 8.4 |
|
|
Baseline |
133.2 ± 161.2 |
|
41.6 ± 49.0 |
|
77.4 ± 135.4 |
|
Desacyl ghrelin (fmol/mL) |
|
|
1.000† |
|
0.002† |
|
0.001† |
|
After 3 months |
108.0 ± 67.7 |
|
101.4 ± 89.3 |
|
115.7 ± 180.7 |
|
|
Baseline |
1692 ± 1903 |
|
3611 ± 2786 |
|
1797 ± 999 |
|
Leptin (pg/mL) |
|
|
0.074* |
|
0.001* |
|
0.000† |
After 3 months | 308 ± 219 | 610 ± 391 | 313 ± 158 |
Data shows mean ± S.D. Abbreviations: T-Chol Total cholesterol, LDL-Chol Low-density lipoprotein cholesterol, HDL-Chol high-density lipoprotein cholesterol. *p stands for the difference between the baseline parameters and the parameters after 3 months analyzed by the paired t-test. †p stands for the difference between the baseline parameters and the parameters after 3 months analyzed by Wilcoxon’s signed rank test. Difference was considered significant at p < 0.05.